Equity Overview
Price & Market Data
Price: $259.4
Daily Change: +$12.89 / 4.97%
Range: $247.0 - $261.6
Market Cap: $18,215,245,824
Volume: 519,183
Performance Metrics
1 Week: 3.45%
1 Month: -4.89%
3 Months: -6.43%
6 Months: 9.68%
1 Year: 57.75%
YTD: -0.65%
Company Details
Employees: 3900
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.